Apoglyx

Apoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients. It focuses on the preclinical development and the commercialization of its patented Aquaporin technology in several disease areas ranging from inflammatory and metabolic diseases to cancer.